The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S
Related Articles
Foods that Fight Digestive Disease
Do you experience uncomfortable bloating in your stomach or burning in your chest after meals? You could be suffering from a digestive disease and Digestive Disease National Awareness month (May) is the opportune time to start working on your... Read More
The Best And Worst Foods For Irritable Bowel Syndrome-IBS
The month of April has been designated as IBS Awareness Month by the International Foundation for Gastrointestinal Disorders to help focus attention on irritable bowel disease – a condition that affects about 10-15% of the population causing GI symptoms... Read More